P10015/SARC033: trametinib in advanced EHE

Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor | RTCL.TVПодробнее

Dr. Caroline Robert Discusses the MEK Inhibitor Trametinib METRIC Trial ResultsПодробнее

Efficacy of trametinib in patients with multiple myeloma with NRAS and KRAS mutationsПодробнее

Professor David Thomas speaks at EHE 360, January 15, 2021Подробнее

COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected stage III BRAF V60...Подробнее

GSK2118436 (dabrafenib) with and without the oral MEK1/2 inhibitor GSK1120212 (trametinib)Подробнее

2022 EHE 360 Patient Conference - Spotlight on EHE ResearchersПодробнее

Late-stage trials in rare sarcoma subtypesПодробнее

David Gershenson, MD, elaborates on the role of MEK inhibitor trametinib in LGSCПодробнее

Dabrafenib plus trametinib preferable to vemurafenib alone in melanomaПодробнее

Trametinib: new treatment for recurrent LGSOCПодробнее

Professor Robin Jones presents at EHE 360 on January 22, 2021Подробнее

What do you see? Try OCT Challenge 15!Подробнее

Helium Integrity Testing HIT™ Technology - Working PrincipleПодробнее

ProImmune REVEAL and ProVE®: Rapid epitope discovery systemПодробнее

Dr. Robert on Potential of Dabrafenib/Trametinib in Melanoma Brain MetastasesПодробнее

Brian Rubin, M.D. Ph.D presents at EHE 360 on January 15, 2021Подробнее

Utilizing the SPECTRALIS® Scan Planning ToolПодробнее

3Mensio CT Pre-case Planning: Valve-in-Valve TAVR in MitroflowПодробнее